BIOMAT Database Logo BIOMAT Database Logo

Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. 1974

H Aström, and H Vallin

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010647 Phenyl Ethers Ethers that are linked to a benzene ring structure. Diphenyl Oxide,Diphenyl Oxides,Diphenyl Ethers,Ethers, Diphenyl,Ethers, Phenyl,Oxide, Diphenyl,Oxides, Diphenyl
D011187 Posture The position or physical attitude of the body. Postures
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests

Related Publications

H Aström, and H Vallin
[Propranolol (a new beta adrenergic blocking agent) in angina pectoris].
January 1967, Archivos del Instituto de Cardiologia de Mexico,
H Aström, and H Vallin
[USE OF A BETA ADRENERGIC BLOCKING AGENT IN ANGINA PECTORIS].
February 1965, La Clinica terapeutica,
H Aström, and H Vallin
A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.
February 1968, Canadian Medical Association journal,
H Aström, and H Vallin
The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
January 1973, Cardiology,
H Aström, and H Vallin
[Our experience with a new beta-adrenergic blocking agent (Practolol) in angina pectoris].
January 1973, Revista espanola de cardiologia,
H Aström, and H Vallin
[Result of a beta-adrenergic (propranolol) blocking agent in angina pectoris].
August 1967, Arquivos brasileiros de cardiologia,
H Aström, and H Vallin
[Use of a new beta-adrenergic blocking agent in angina pectoris patients (Ba 39'089)].
June 1968, Prensa medica argentina,
H Aström, and H Vallin
Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
May 1969, Annals of clinical research,
H Aström, and H Vallin
[Treatment of angina pectoris with an adrenergic beta receptor blocking agent].
January 1966, Medizinische Klinik,
H Aström, and H Vallin
Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
January 1986, The Journal of international medical research,
Copied contents to your clipboard!